Holbrook, United States
Airgle Corporation, founded in 1999, is a leading manufacturer of professional-grade air purification systems headquartered in New York, United States. The company offers a range of purification solutions, including stand-alone and HVAC-compatible systems engineered to combat airborne pathogens, ultra-fine particulates, and VOCs in various indoor settings.
One of Airgle's key innovations is its exclusive cHEPA filter, with a capture threshold down to 0.003 microns and an ultraviolet titanium module that can irradiate viruses and other pathogens using photocatalytic oxidation technology. Notably, the company's systems have undergone third-party testing, including by a Biosafety Level 3 (BSL-3) laboratory, confirming their ability to capture and contain airborne microbial pathogens.
The company's AG900 air purification devices have demonstrated a remarkable reduction of greater than 99.998% of recoverable active SARS-CoV-2 virus in the air after 60 minutes of operation, as confirmed by testing. Such results underline the efficacy of Airgle's purification technology in combating infectious agents.
Airgle's solutions have gained traction across various industries, including hospitals, clinics, schools, HVAC contractors, offices, hotels, restaurants, and retail establishments, positioning the company as a frontrunner in the indoor air quality market. Its global distribution network covers North America and extends to countries such as Canada, Germany, India, Singapore, China, and many others.
While specific investment details are not available at this time, Airgle Corporation's pioneering technology and widespread adoption in critical sectors make it a compelling prospect for potential investors seeking opportunities in the manufacturing and air purification industries.
